David P. Southwell
CIK: 0001251553
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Aug 3, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Other(J)Direct150K shares- - Jun 18, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Award(A)Direct22.9K shares- - Jan 2, 2026PTCT
PTC THERAPEUTICS, INC.
Award(A)Direct4K shares- - Sep 9, 2025PTCT
PTC THERAPEUTICS, INC.
Sale(S)Direct12K shares at avg. $58.34$700K - Sep 9, 2025PTCT
PTC THERAPEUTICS, INC.
Exercise(M)Direct12K shares at avg. $30.86$370K - Jun 18, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
Award(A)Direct30K shares- - Jan 3, 2025PTCT
PTC THERAPEUTICS, INC.
Award(A)Direct4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 3, 2026 |  RCKT ROCKET PHARMACEUTICALS, INC. | Other(J) | 150,000 | - | $0 | Direct |
| Jun 18, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Award(A) | 22,862 | - | $0 | Direct |
| Jan 2, 2026 |  PTCT PTC THERAPEUTICS, INC. | Award(A) | 4,000 | - | $0 | Direct |
| Sep 9, 2025 | PTCT PTC THERAPEUTICS, INC. | Sale(S) | 12,000 | $58.34 | $700,080 | Direct |
| Sep 9, 2025 | PTCT PTC THERAPEUTICS, INC. | Exercise(M) | 12,000 | $30.86 | $370,320 | Direct |
| Jun 18, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | Award(A) | 30,000 | - | - | Direct |
| Jan 3, 2025 | PTCT PTC THERAPEUTICS, INC. | Award(A) | 4,000 | - | $0 | Direct |
1-7 of 7 transactions
About SOUTHWELL DAVID P
SOUTHWELL DAVID P (SEC CIK 0001251553) files insider reports with the SEC as Director of ROCKET PHARMACEUTICALS, INC. (RCKT) and Director of PTC THERAPEUTICS, INC. (PTCT).
Signal8 holds 6 ownership filings by SOUTHWELL DAVID P, all Form 4s, filed between Jan 7, 2025 and Aug 5, 2026. Those filings report 7 transactions, from Jan 3, 2025 to Aug 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on SOUTHWELL DAVID P's filings is in CRANBURY, NJ.
Recent filings by SOUTHWELL DAVID P
- Aug 3, 2026: Other transaction of RCKT shares (Form 4, code J).
- Jun 18, 2026: Grant or award of RCKT shares (Form 4, code A).
- Jan 2, 2026: Grant or award of PTCT shares (Form 4, code A).
- Sep 9, 2025: Open-market sale of PTCT shares (Form 4, code S).
- Sep 9, 2025: Option exercise of PTCT shares (Form 4, code M).
Other insiders filing for ROCKET PHARMACEUTICALS, INC. (RCKT)
- Wilson Martin, General Counsel
- Shah Gaurav, CEO
- Stevens Christopher James, Chief Operating Officer
- Chaudhuri Sarbani
- Manhede Joseph, Principal Accounting Officer
- WONG RODERICK, Director